Corrigendum to "RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7" [Biochem. Pharmacol. 180 (2020) 114118]

Affiliations

• ¹ Key Laboratory of Pathobiology, Ministry of Education, and Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun 130021, PR China.
• ² Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
• ³ Greenebaum NCI Comprehensive Cancer Center, Department of Microbiology and Immunology University of Maryland School Medicine, Baltimore, MD, USA.
• ⁴ Department of Biochemistry and Molecular Biology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA.
• ⁵ Department of Plastic Surgery, China-Japan Union Hospital of Jilin University, Changchun 130033, PR China. Electronic address: gbf@jlu.edu.cn.
• ⁶ Key Laboratory of Pathobiology, Ministry of Education, and Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun 130021, PR China. Electronic address: zhangling3@jlu.edu.cn.